A Study in People With Abnormal Fat Levels in the Blood

NCT00116519 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: PPAR alpha
DRUG: placebo

Sponsor

Eli Lilly and Company